HLS13-13 albumin nanoparticle based technology to treat ards

Ended Project Grant Awarded Last action

Award ID
R41HL126456
Recipient
Awarding agency
Obligated
$668,170

Award facts

Assistance listing
93.837 Cardiovascular Diseases Research
Completion date
Place of performance
Chicago, IL 60612, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment -$9,954
Amendment HLS13-13 albumin nanoparticle based technology to treat ards - description (provided by applicant): severe infections, various types of trauma, and other… -$9,954
Amendment $344,039
Original award $344,039

Quick answers

Who received award R41HL126456?

R41HL126456 was awarded to Cell Biologics, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on December 1, 2014.

How much is award R41HL126456 worth?

$668,170 has been obligated on R41HL126456.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award